Dr. Naif Khalaf Alharbi

Scientific Advisor


  • Postdoctoral, Vaccine Development, University of Oxford, UK, 2016.
  • Doctor of Philosophy (DPhil) in Clinical Medicine (Molecular Virology and Vaccinology), Oxford, UK 2015.
  • Masters’ in Molecular Medical Microbiology, University of Nottingham, UK, 2010.
  • Bachelors’ in Medical Microbiology, Qassim University, Saudi Arabia, 2006.
  • Certificates of training in Vaccinology, Immunology, Vaccine Biomanufacturing, Oxford, UK


  • Director, Vaccine Development Unit, KAIMRC.
  • Director, Research Quality Management, KAIMRC.
  • Head, Research Biosafety Office, KAIMRC.
  • Research Scientist, Infectious Diseases, KAIMRC.
  • Visiting Fellow, the Jenner Institute, University of Oxford (2018 – 2021).
  • PI on several vaccine, virology, and immunology research projects: incl. animal and clinical trial research.
  • Co-developed a MERS vaccine (ChAdOx1-MERS): Leading its evaluation in camel trials and human phase I trial (incl. trial conduct and regulation pathways).
  • Member in :- CEPI Vaccine TaskForce for standardisation of assays
    – International Society of Vaccines
    – Research Committees: incl. Research Animal Ethics; Research Misconduct;
    Research Credentialing; Research Funding; Research Management;
    Research Quality.
    – National biosafety lab committee.
    – National scientific committee for COVID-19 vaccines.
    – Judging committee for a number of national research Contests and Olympics.
  • Patent: 4 patents on vaccine development (2 registered & 2 under submission).
  • Publications (incl in-press): ~ 18.
  • Ten years experience in vaccine development: incl. vaccine tissue culture, small scale production, vaccine QC, vaccine regulations, vaccine preclinical and clinical trial lab
  • Collaboration with several international vaccine institutes.


Clinical Medicine